AcelRx Pharmaceuticals, Inc.
- Targets
- 1
- Filings
- 1
- Median premium
- 63%
- First filing
- Apr 24, 2020
- Latest filing
- Apr 24, 2020
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| TETRAPHASE PHARMACEUTICALS INC | — | — | 1 | Apr 24, 2020 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Apr 24, 2020 | TETRAPHASE PHARMACEUTICALS INC | DEFM14A | $0.63 | 63.03% |